ROYAL BANK OF CANADA - NEOS THERAPEUTICS INC ownership

NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 70 filers reported holding NEOS THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 4.94 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of NEOS THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$3,0000.0%4,1000.0%0.00%
Q1 2020$3,000
-75.0%
4,100
-49.4%
0.00%
Q4 2019$12,0000.0%8,1000.0%0.00%
Q3 2019$12,000
-25.0%
8,100
-35.7%
0.00%
Q2 2019$16,000
-51.5%
12,6000.0%0.00%
Q1 2019$33,00012,600
+629900.0%
0.00%
Q4 2018$0
-100.0%
2
-99.8%
0.00%
Q3 2018$5,000
-70.6%
1,141
-56.7%
0.00%
Q2 2018$17,000
+325.0%
2,635
+418.7%
0.00%
Q1 2018$4,000
-55.6%
508
-41.1%
0.00%
Q4 2017$9,000
-70.0%
863
-73.3%
0.00%
Q3 2017$30,000
+400.0%
3,234
+252.3%
0.00%
Q2 2017$6,000
-40.0%
918
-34.8%
0.00%
Q1 2017$10,0000.0%1,408
-20.0%
0.00%
Q4 2016$10,000
+100.0%
1,760
+134.7%
0.00%
Q3 2016$5,000
-28.6%
7500.0%0.00%
Q2 2016$7,000
-12.5%
7500.0%0.00%
Q1 2016$8,000
+100.0%
750
+275.0%
0.00%
Q3 2015$4,0002000.00%
Other shareholders
NEOS THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
DSC Advisors, L.P. 693,582$4,057,0002.30%
DAFNA Capital Management LLC 38,873$227,0000.20%
FALCON POINT CAPITAL, LLC 85,588$501,0000.07%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 229,166$1,341,0000.06%
Cormorant Asset Management, LP 50,613$296,0000.04%
PRELUDE CAPITAL MANAGEMENT, LLC 14,587$85,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 80,000$468,0000.01%
MILLENNIUM MANAGEMENT LLC 296,175$1,733,0000.00%
FRANKLIN RESOURCES INC 1,315,500$7,696,0000.00%
COLUMBUS CIRCLE INVESTORS 42,304$247,0000.00%
View complete list of NEOS THERAPEUTICS INC shareholders